Press release
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry ReportA Recent Market Study On Chagas Disease And Its Current Trends And Future Insights
Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen lymph nodes, fever, headache, and local swelling at the site of the bite. The chronic symptoms will appear after 8-12 weeks that may include expansion of ventricles leading to heart failure, irregular heartbeat, difficulty in swallowing, and abdominal or colon pain.
Request Sample Report: https://precisionbusinessinsights.com/request-sample?product_id=15817
Rise in the prevalence of Chagas disease due to unhygienic conditions are factors leading to the growth of Chagas disease drugs market. In addition, increase in the R & D of new products are one of the main factors for the market growth. However, lack of awareness regarding the Chagas disease treatment, a limited number of approved products in the current market, and supply chain issues with Chagas disease drugs will hamper the Chagas disease drugs market growth.
The global Chagas disease management market is categorized as under-
1. Type of treatment
• Anti-parasitic treatment
• Symptomatic treatment
2. Drug type
• Benznidazole
• Nifurtimox
3. End-users
Hospital, Online and retail pharmacies
And lastly, on the basis of geographical regions, the global Chagas disease management market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Latin America is the major center for Chagas disease and gradually developing in the rest of world owing to the population mobility from Latin America. Less number of products available in the market for treatment, and poor diagnostic methods to detect in the Latin America region are the major challenges for the Chagas disease treatment market in this region. North America and Europe are the key regions for Chagas disease therapeutic vaccine market owing to increase in the prevalence of Chagas disease.
Some of the key players in Chagas disease therapeutic vaccine market are AstraZeneca (U.K), Bayer AG (Germany), Daiichi Sankyo Company Ltd (Japan), Eisai Co Ltd (Japan), GlaxoSmithKline Plc. (U.K), Grupo Praxis Pharmaceutical SA (Spain), Kancera AB (Sweden), Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Oblita Therapeutics BVBA (Belgium), and Sanofi Aventis (France) to name a few. In 2017, Daiichi Sankyo Company Limited and Drugs for Neglected Diseases initiative (DNDi) are collaborated to form a joint research with regard to a new research program, the hit-to-lead project to develop the drugs for Chagas disease and Leishmaniasis.
Global Chagas disease management market is still in the budding stage. Currently, very few players are actively involved in the development of new products for the treatment. Several products are in pipeline that may enter the market near future. Increase in R & D for new products, acquisitions & mergers, collaborations and providing funds to various organizations can fuel the market growth for Chagas disease treatment market. For instance, in 2012, Japan’s Astellas Pharma signed an agreement with the Drugs for Neglected Diseases initiative (DNDi) to collaborate on drug discovery research for three neglected tropical diseases: leishmaniasis, Chagas disease, and sleeping sickness.
For More Information : https://precisionbusinessinsights.com/market-reports/global-chagas-disease-management-market/
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2018 – 2024 Chagas Disease Management Market | Global Industry Report here
News-ID: 1572394 • Views: …
More Releases from Precision Business Insights

Gaming Controller Market Rising Demand for Gaming Stations and eSports
According to the Precision Business Insights (PBI), latest report the gaming controller market size was valued at USD 2,382.1 million in 2023, growing at an 8.5% CAGR from 2024 to 2030. The key drivers of the expansion of the global gaming controller include the enhanced gaming experience, technology advancements, consumer preferences and ergonomics, competitive gaming and esports, intuitiveness, and portability of the gaming controllers.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/gaming-controller-market …

Next Generation Dietary Supplements Market Size, Growth Opportunities 2024-2030
According to Precision Business Insights (PBI), the latest report, the global next-generation dietary supplements market was valued at USD 10,752.3 million in 2023 and is expected to grow at a CAGR of 8.8% from 2024-2030. The primary factors that drive the market are the growing demand for rising consumer knowledge of the various health benefits of Next Generation Dietary Supplements, as well as rising disposable income levels, fuel market expansion…

Catamaran Market Increasing Popularity Of Water Sports And Fishing Activities
According to Precision Business Insights (PBI), the latest report, the catamaran market is valued at USD 1,635.7 million in 2023 and is anticipated to grow a CAGR of 4.9% over the forecast period. The primary factors that drive the market are the growing demand for Catamaran pushes the market to enhance efficiency, minimize time consumption, and reduce post-harvest operating losses. Catamaran are good solutions for reducing high labour costs since…

Refrigerated Display Cases Market Size, Share, Growth Trends and Forecast 2024-2 …
According to Precision Business Insights (PBI), latest report, the refrigerated display cases market was valued at USD 8,248.5 million in 2023 and is expected to grow at a 5.1% CAGR from 2024 to 2030. The primary drivers of the expansion of the global refrigerated display cases market include the increasing demand for frozen food and drinks among urban consumers. In addition, growing awareness about environment sustainability and energy efficiency is…
More Releases for Chagas
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 .
Chagas Disease Treatment Market Overview
Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,…
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to…
Chagas Disease Drug Market Size To Touch USD 520.4 Million By 2032
Chagas Disease Drug Market Size to Occupy More Than USD 520.4 Million by 2032 | CAGR 7.1% from 2023 to 2032
The Chagas Disease Drug Market research report published by Acumen Research and Consulting provides a comprehensive yet detailed analysis of the global market landscape. The report helps our clients understand the market scenario while also providing a detailed historical account of the market over the previous years. The Chagas Disease…
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…